The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...

In his resignation letter, Dr. Peter Marks cited “misinformation and lies” from Health and Human Services Secretary RFK Jr.

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

Synthetic dyes used to make brightly colored cereals, drinks and candies are coming under scrutiny in states across the ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

New medicines are being developed for individual treatments based on someone’s DNA. Those would be allowed under a proposed ...